Table 4.

US white versus Norwegian patients’ relative risk for progression from CKD stages 3 or 4 to ESRDa

Per 100,000 Adults in General PopulationRatio, ESRD Incidence/CKD PrevalenceIncreased Risk for US White Patients
CKD Stages 3 to 4New ESRD per Year
Total2.5
    US white501030.80.0061
    Norway436010.60.0024
Nondiabetes2.0
    US white377216.70.0044
    Norway38708.60.0022
Diabetes2.8
    US white123814.10.0114
    Norway4902.00.0041
Age < 60 yr1.7
    US white71311.10.0156
    Norway5084.70.0093
Age ≥ 60 yr3.0
    US white434919.70.0045
    Norway38355.90.0015
Female3.5
    US white319813.90.0043
    Norway29933.60.0012
Male1.9
    US white185216.90.0091
    Norway14077.00.0049
  • a Prevalence (per 100,000 adults) of CKD stages 3 to 4 is from the Third National Health and Nutrition Examination Survey (NHANES III; 1988 to 1994, which is not significantly different from NHANES 1999 to 2000) and from HUNT II (1995 to 1997). Incidence of ESRD (per 100,000 adults per year) is from the US Renal Data System (USRDS; 1995 to 1997) and from the Norwegian Renal Registry (1995 to 1997). Data on patients with diabetes represent CKD or ESRD in patients with diabetes as primary renal diagnosis or as a secondary complicating diagnosis (25,39,4446).